Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Buildings: 2018-2019

  • China SXT Pharmaceuticals' Buildings was N/A to $268,803 in Q3 2019 from the same period last year, while for Sep 2019 it was $268,803, marking a year-over-year change of. This contributed to the annual value of $155,000 for FY2018, which is N/A change from last year.
  • China SXT Pharmaceuticals' Buildings amounted to $268,803 in Q3 2019, which was up 73.42% from $155,000 recorded in Q1 2018.
  • Over the past 5 years, China SXT Pharmaceuticals' Buildings peaked at $268,803 during Q3 2019, and registered a low of $155,000 during Q1 2018.
  • In the last 2 years, China SXT Pharmaceuticals' Buildings had a median value of $211,902 in 2018 and averaged $211,902.